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Objective: Some, but not all, granulosa cell tumors are characterized by estrogen production. 
This study was designed to determine whether there are clinical or pathological variations in 
granulosa cell tumors in relation to the expression of sex steroid synthesis enzymes.
Methods: Clinical symptoms, serum hormonal values, and histology of 30 granulosa 
cell tumor patients who underwent surgery between 2002 and 2014 were retrospectively 
reviewed.
Results: Most patients presented with abnormal genital bleeding including abnormal 
menstrual cycles. Eight of 16 patients older than 50 years had endometrial hyperplasia and 
one had endometrial cancer. Serum 17β-estradiol (E2) levels tended to be higher in patients 
over 50 years of age (p=0.081). Serum follicle-stimulating hormone (FSH) levels were low in 
all patients irrespective of serum E2 levels. Magnetic resonance imaging revealed a thicker 
endometrium in older as compared to younger patients (p<0.05). Tumor cells in the majority 
of cases were positive for inhibin α and P450 aromatase, irrespective of age and serum E2 
levels. P450 17α-hydroxylase (P450c17) expression varied among cases. P450c17 was strongly 
positive in luteinized tumor cells and weakly positive in theca cells and fibroblasts. High E2 
levels were associated with P450c17-positive cells in the tumor (p<0.05).
Conclusion: The expression of hormone-synthesizing enzymes divides granulosa cell 
tumors into 2 distinct types; tumors with P450c17-positive cells show elevated serum E2 and 
related clinical symptoms, while tumors without these cells show symptoms related to FSH 
suppression by inhibin.
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INTRODUCTION
Ovarian granulosa cell tumors are a form of sex-cord stromal tumors that account for 1%–2% 
of all ovarian tumors and can be of the juvenile or adult type [1]. Adult granulosa cell tumors 
are common among women in their fifties and are known for estrogen production, although 
about 30% of cases do not produce estradiol [2]. The major symptom of granulosa cell 
tumors is postmenopausal genital bleeding, which is attributed to estrogen production [3].
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About 50% of granulosa cell tumors are accompanied by endometrial hyperplasia, and 10% 
by endometrial carcinoma [4]. Disease activity is reflected by serum levels of inhibin B and 
anti-Müllerian hormone, but not estrogen [5,6]. Adult granulosa cell tumors can be classified 
pathologically into several types, according to morphology, as diffuse, microfollicular, 
macrofollicular, insular, and corded to trabecular [1]. However, the current pathological 
classification does not associate with the clinical symptoms or the behavior of the neoplasm. 
Moreover, few studies have analyzed the pathology and clinical symptoms in relation to 
hormone production.
To address this issue, the present study investigated clinical or pathological variations in 
granulosa cell tumors and their relationship to the expression of sex steroid synthesis enzymes.
MATERIALS AND METHODS
1. Samples and patient information
Central pathology data was used to confirm the diagnosis of adult granulosa cell tumors in 
30 patients who underwent surgery at Kyoto University Hospital, Kinki University Hospital, 
or Hiroshima City Asa Citizens Hospital between 2002 and 2014. The records of clinical 
symptoms and serum hormone levels were retrospectively reviewed. Pregnant cases were 
excluded from the study. Written, informed consent was obtained from each patient. The 
study protocol was approved by the ethics committees of all 3 institutions.
2. Immunohistochemistry
Formalin-fixed, paraffin-embedded tumor tissue sample blocks were cut into 4-µm 
sections and stained with hematoxylin and eosin, or used for immunohistochemistry by the 
streptavidin-biotin-peroxidase method with the following antibodies: monoclonal mouse 
anti-inhibin α (M3609; Dako, Carpinteria, CA, USA), anti-P450 aromatase (22PS, SM 22; 
Acris, San Diego, CA, USA), and rabbit polyclonal anti-P450 17α-hydroxylase (P450c17) (LS-B 
6749; LSBio, Seattle, WA, USA).
3. Evaluation of specimens
The expression of inhibin α, P450c17, and P450 aromatase was evaluated according to the 
intensity of the staining and scored as follows: 0, negative; 1, weak; 2, strong. Testis tissue 
was probed as a positive control for inhibin α and P450c17, and a normal ovarian follicle for 
P450 aromatase.
4. Statistical analysis
Fisher's exact test, the Mann-Whitney test, and analysis of variance (ANOVA) were carried out 
using GraphPad Prism v.6 software (GraphPad, La Jolla, CA, USA). A p-value less than 0.05 
was considered significant.
RESULTS
Clinical information of the 30 patients is shown in Table 1 and Supplementary Table 1. The 
mean age was 50.2 years; 14 patients were under and 16 over 50 years of age (younger and older 
groups, respectively). Abnormal genital bleeding, mainly representing abnormal menstrual 
cycles, was reported by 78.0% of patients in the younger group. Abnormal genital bleeding, 
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mainly as postmenopausal bleeding, was reported by 87.5% of patients in the older group. 
Of the 30 patients, 28 were in International Federation of Gynecology and Obstetrics (FIGO) 
stage I. There was no significant difference in prognosis between younger and older groups.
A total of 16 patients underwent both salpingo-oophorectomy and hysterectomy. Three 
other patients underwent endometrial biopsy. Endometrial tissue specimens were available 
from a total of 19 patients. Two patients in the younger group had endometrial hyperplasia. 
Eight patients had endometrial hyperplasia and 1 had endometrioid adenocarcinoma in the 
older group.
Preoperative serum 17β-estradiol (E2) values were available for all 21 patients from the 2 
institutions (Kyoto University Hospital and Kinki University Hospital) and not available for 
the other 9 patients form the other institution (Hiroshima Asa Citizens Hospital).
The values were greater than 30 pg/mL in 4 patients (36%) under 50 years of age and in 7 
patients (64%) over 50 years of age. Serum E2 values tended to be higher in patients over 
50 years of age than in those under 50 years of age (Table 2), though the difference was not 
statistically significant (p=0.081; Fisher's exact test). Serum follicle-stimulating hormone 
(FSH) values were low in all patients where it was measured, irrespective of age and serum E2 
levels. Specifically, both serum E2 and FSH levels tended to be low in patients under 50 years 
of age, whereas those over 50 years of age tended to show high serum E2 and low FSH levels.
To investigate the influence of estrogen on the endometrium, we compared endometrial 
thickness in magnetic resonance images from patients under and over 50 years of age. In 
the former group, the mean endometrial thickness was 4.0 mm, whereas a large uterus 
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Table 1. Patients' profile of this study
Variables <50 years old (n=14) ≥50 years old (n=16)
Symptoms
Abnormal genital bleeding 11 14




Low abdominal pain 2 2
Others Masculinization 1 Abnormal discharge 1








Hyperplasia (atypical/simple) 2 (2/0) 8 (5/3)
Adenocarcinoma 0 1
Not available 6 5
FIGO, International Federation of Gynecology and Obstetrics.
Table 2. Relationship of patients' age and serum E2 values
Variables <50 years old (n=14) ≥50 years old (n=16)
E2<30 pg/mL 8 2
E2≥30 pg/mL 4 7
p=0.08 by Fisher's exact test.
E2, 17β-estradiol.
and significantly thicker endometrium (mean: 9.7 mm; p=0.013; Mann-Whitney test) were 
observed in the latter group despite the age of these patients (Fig. 1A and 1B).
Immunohistochemical analysis of the 30 cases revealed that inhibin α and P450 aromatase 
were expressed in tumor cells in a majority of cases regardless of patient age and serum E2 
levels (Fig. 2, Supplementary Table 2). Strong P450c17 immunoreactivity was observed in 
luteinized cells with abundant eosinophilic cytoplasm, while some other tumor cells, as well 
as theca and fibroblast-like cells, were weakly positive (Fig. 3A). Luteinized cells were also 
strongly positive for inhibin α and P450 aromatase (Supplementary Fig. 1).
P450c17-positive (score 1 and 2) cases were more frequent in the older patient group than in 
the younger group (Fig. 3B; p=0.009; Fisher's exact test). The presence of P450c17-positive 
cells was significantly correlated to high E2 levels (>30) (Fig. 3C; p=0.030; Fisher's exact test). 
There was no significant difference in prognosis in terms of the serum E2 values.
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Fig. 1. Endometrial thickness. (A) Magnetic resonance imaging of representative cases (T2 weighted images, 
sagittal sections). Left: 34-year-old woman whose serum E2 level was 16.8 pg/mL with an endometrial thickness 
of 8.69 mm. Right: 71-year-old woman whose serum E2 level was 81.4 pg/mL with an endometrial thickness of 
21.70 mm. (B) Differences in the endometrial thickness between patients under and over 50 years of age. Data are 
presented as mean±SD.
E2, 17β-estradiol; Em, endometrial; SD, standard deviation.
*p<0.05 (Mann-Whitney test).
DISCUSSION
This study is the most extensive immunohistochemical analysis to date of inhibin and 
hormone-synthesizing enzyme expression in adult granulosa cell tumors. Our review of 
30 cases revealed that nearly all granulosa cell tumors were positive for inhibin α and P450 
aromatase expression (Fig. 2, Supplementary Table 2). Inhibin is a heterodimer composed 
of α and β subunits. There are 2 types of the β subunit, A and B, that form inhibin A and B, 
respectively. One study found that the expression of inhibin B was elevated in about 90% 
of granulosa cell tumors in 30 patients aged 24 to 80 years [7]. Secondary amenorrhea seen 
in granulosa cell tumor cases may be caused by excessive production of inhibin B by the 
tumor [8]. Indeed, the pattern of hormonal expression in those cases resembled that of FSH 
deficiency (i.e., low FSH and high luteinizing hormone [LH] levels). Inhibin suppressed 
FSH production from the pituitary gland [9], resulting in irregular menstrual cycles in 
premenopausal cases of granulosa cell tumors. Although serum inhibin levels were not 
measured in any patients in the present study, 93% were immunohistochemically positive for 
inhibin α. Serum FSH levels were low irrespective of age and serum E2 level (Supplementary 
Table 2), indicating that inhibin production was a major feature of granulosa cell tumors and 
providing an explanation for the irregular menses, particularly oligo-amenorrhea, observed 
in the premenopausal patients.
Although granulosa cell tumors are known for E2 production, serum E2 levels were low in 
33% of our cases. Interestingly, 67% of patients under 50 years of age showed low E2 levels 
(<30 pg/mL), whereas 78% of patients over 50 years of age showed higher levels (>30 pg/
mL) (Table 2). This is contrary to normal women in whom the serum E2 level is high in the 
premenopausal state and low after menopause.
In this study, the effect of estrogen on the uterine endometrium was investigated 
by examining its thickness and histopathology. The magnetic resonance images 
revealed significant thickening of the endometrium in older patients (Fig. 1B), while 
the histopathological examination showed endometrial hyperplasia and endometrioid 
adenocarcinoma in many of these cases (Table 1). These results were consistent with the 
previous report that E2 levels were not elevated in about 30% of granulosa cell tumor patients 
[2] and that few granulosa cell tumors in patients under 40 years of age were accompanied by 
atypical endometrial hyperplasia or endometrioid adenocarcinoma [4]. Collectively, our data 
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H&E Inhibin ɑ P450 aromatase
Fig. 2. Inhibin α and P450 aromatase expression. Representative images of inhibin α and P450 aromatase expression as determined immunohistochemically.
H&E, hematoxylin and eosin staining (original magnification: ×40).
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Fig. 3. Relationships between P450c17 expression and patient age and serum E2 levels. (A) Representative images of P450c17 expression. Samples are strongly 
positive (score 2) for P450c17 in luteinized cells (left upper), and weakly positive (score 1) for P450c17 in theca- or fibroblast-like cells (middle upper) and tumor 
cells (upper right), as determined by immunohistochemistry (original magnification: ×40). (B) Number of cases positive (score 1 or 2) or negative (score 0) for 
P450c17 among patients under and over 50 years of age (n=14 and 16, respectively). (C) Number of cases positive or negative for P450c17 among patients with 
serum E2 below or above 30 pg/mL (n=10 and 11, respectively).
E2, 17β-estradiol; H&E, hematoxylin and eosin staining; ns, not significant; P450c17, P450 17α-hydroxylase.
*p<0.05 (B, C: Fisher's exact test).
indicate that the estrogenic effect on the endometrium in postmenopausal women results in 
genital bleeding, and that negative feedback by estrogen or production of inhibin results in 
FSH suppression that is unusual for their age.
We examined the histopathological features of the tumors to explain the observed differences 
in serum E2 levels. The “2-cell, 2-gonadotropin theory” of normal ovarian follicles postulates 
that ovarian theca cells produce androgen that is converted by granulosa cells into estrogen 
[10]. In theca cells, cholesterol is first converted to pregnenolone by P450 cholesterol side-
chain cleavage. The pregnenolone is then converted to androstenedione by 3β-dihydroxysteroid 
dehydrogenase and P450c17. Androstenedione moves into granulosa cells and is converted to 
estrone and estradiol by P450 aromatase. P450c17 is exclusively localized in theca cells [11]. 
Consequently, granulosa cells and theca cells are both critical for estrogen production.
The 2-cell, 2-gonadotropin theory has been applied to granulosa cell tumors. Many of these 
tumors have luteinized theca-like cells in the stroma, and these so-called theca reaction 
cases tend to show hormonal symptoms [12]. Typical granulosa tumor cells lack the ability 
to produce these hormones, whereas cells with a clear cytoplasm express steroid synthesis 
enzymes and are the source of hormones in granulosa cell tumors [11]. In the present study, 
luteinized cells were strongly positive, and other tumor cells and theca-like cells were weakly 
positive, for P450c17. Furthermore, P450c17-positive cases showed elevated serum E2 levels. 
Our data indicate that the expression of P450c17 regulates estrogen production in granulosa 
cell tumors and that the mechanism of hormone production in these tumors is similar to the 
2-cell, 2-gonadotropin theory in normal ovaries.
Inhibin expressed by granulosa cell tumors suppresses FSH release from the pituitary gland 
and consequently, estrogen production from the normal ovary. P450c17 in luteinized and 
other cells synthesizes androgen, which is transformed into estradiol in granulosa and 
luteinized cells. Our data show that some tumors lacked P450c17-positive cells, resulting in 
low estrogen production probably due to the absence of androgen (Fig. 3B).
Overall, this study is the first to demonstrate the close relationship between serum E2 levels 
and P450c17 expression in granulosa cell tumors. Our results also revealed that granulosa cell 
tumors without P450c17-positive cells tended to arise in younger patients who consequently 
showed lower serum E2 levels than older patients. The reason why these tumors occur in 
younger women is unclear, and requires further investigation.
One of possible limitations of this study is the lack of data on FOXL2 mutation, which is 
identified in about 94%–97% in adult granulosa cell tumors. A specific point mutation 
(c.402C>G [C134W]) in the FOXL2 is likely to contribute to adult granulosa cell tumor 
development and a number of genes are known to be regulated by FOXL2, including p450 
aromatase/CYP19A1 [13,14]. Other limitations include the small sample size, lack of data 
on hormone synthesis for tissues other than tumors, and the fact that expression of 
steroidogenic enzymes does not necessarily reflect their activities. Nonetheless, this study 
characterized unique cellular functions and related symptoms in this rare tumor type.
In summary, we analyzed 30 cases of adult granulosa cell tumors, focusing on the 
relationship between the expression of hormone-synthesizing enzymes and clinical 
symptoms. Our data indicate that, in order to produce estrogen, not only granulosa cells 
expressing aromatase but also cells expressing androgen-synthesizing enzymes are necessary. 
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Granulosa cell tumors lacking the latter cell types occur in relatively young women, and lack 
estrogenic manifestations. Granulosa cell tumors comprised of both cell types tend to occur 
in older women, and clinicians should pay attention to possible endometrial malignancy in 
these cases. Thus, dividing granulosa cell tumors into 2 types by the presence or absence of 
cells expressing androgen-synthesizing enzymes may help improve our understanding of the 
features of this rare tumor.
SUPPLEMENTARY MATERIALS
Supplementary Table 1
Representative additional patients' profile
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Supplementary Table 2
Representative immunohistochemistry results
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Supplementary Fig. 1
Representative images of inhibin α, P450 aromatase, and P450c17 expression in luteinized 
cells, as determined by immunohistochemistry.
H&E, hematoxylin and eosin staining; P450c17, P450 17α-hydroxylase.
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